Volume 68 Received 4 November 2012 | ||||||||||
| ||||||||||
aDepartment of Physics, Faculty of Sciences, Erciyes University, 38039 Kayseri, Turkey,bDepartment of Pure & Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, Scotland,cDepartment of Chemistry, Faculty of Science, Sohag University, 82524 Sohag, Egypt,dChemistry and Environmental Division, Manchester Metropolitan University, Manchester M1 5GD, England, and eChemistry Department, Faculty of Science, Minia University, 61519 El-Minia, Egypt
Correspondence e-mail: akkurt@erciyes.edu.tr, a.r.Kennedy@strath.ac.uk
In the title compound, C15H12N2O, the phenyl ring makes a dihedral angle of 32.45 (9)° with the benzene ring of the 1,5-benzodiazepin-2-one unit. The seven-membered ring adopts a boat conformation with the methylene group as the prow and the fused benzene-ring C atoms as the stern. In the crystal, inversion dimers linked by pairs of N-H
O hydrogen bonds generate R22(8) loops. The dimers are further linked by C-H
O hydrogen bonds, so forming a column along the a-axis direction.
For background to benzodiazepine compounds, see: McKernan (2000
); Thakur et al. (2003
). For related structures, see: Benelbaghdadi et al. (2003
); Visnjevac et al. (2002
).
|
|
| ||||||||||||||||||||||
Data collection: CrysAlis PRO (Oxford Diffraction, 2010
); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012
) and PLATON (Spek, 2009
); software used to prepare material for publication: WinGX (Farrugia, 2012
) and PLATON.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HB6983 ).
Manchester Metropolitan University, Erciyes University and University of Strathclyde are gratefully acknowledged for supporting this study.
Benelbaghdadi, R., Hasnaoui, R. A., Lavergne, J. P., Ait Itto, M. & Pierrot, M. (2003). Acta Cryst. E59, o143-o144.
![[details]](../../../../../../e/graphics/details.gif)
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
![[details]](../../../../../../j/graphics/details.gif)
McKernan, R. M. (2000). Nat. Neurosci. 3, 587-592.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Oxford Diffraction (2010). CrysAlis PRO. Oxford Diffraction Ltd, Yarnton, England.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Thakur, A., Thakur, M. & Khadikar, P. V. (2003). Bioorg. Med. Chem. 11, 5203-5207.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Visnjevac, A., Avdagic, A. & Kojic-Prodic, B. (2002). Acta Cryst. E58, o148-o150.
![[details]](../../../../../../e/graphics/details.gif)